AnGes Inc (4563):企業の財務・戦略的SWOT分析

◆英語タイトル:AnGes Inc (4563) - Financial and Strategic SWOT Analysis Review
◆商品コード:GDPH81963FSA
◆発行会社(調査会社):GlobalData
◆発行日:2021年3月
◆ページ数:39
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:日本
◆産業分野:Pharmaceuticals and Healthcare
◆販売価格オプション(消費税別)
Site License(同一事業所内共有可)USD250 ⇒換算¥33,250見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD375 ⇒換算¥49,875見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

AnGes Inc (4563) – Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
The profile contains critical company information including:

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

AnGes Inc (AnGes) is a biopharmaceutical company which discovers and develops gene and nucleotide based drugs and reagents for use in functional analysis of genetic medication. The company specializes in research and development (R&D) and practical application of genetic medicine. It has two main projects under development, namely, a hepatocyte growth factor (HGF) plasmid, a genetic medicine that regenerates blood vessels improving blood circulation and NF-KB decoy oligonucleotide. It also develops therapeutic vaccine projects including CIN (cervical intraepithelial neoplasia) therapeutic vaccines. The company has operations in Jaoan and the US. AnGes is headquartered in Osaka, Japan.

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

【レポートの目次】

Table of Contents
List of Tables
List of Figures
Section 1 – About the Company
AnGes Inc – Key Facts
AnGes Inc – Key Employees
AnGes Inc – Key Employee Biographies
AnGes Inc – Major Products and Services
AnGes Inc – History
AnGes Inc – Company Statement
AnGes Inc – Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Section 2 – Company Analysis
Company Overview
AnGes Inc – Business Description
AnGes Inc – Corporate Strategy
AnGes Inc – SWOT Analysis
SWOT Analysis – Overview
AnGes Inc – Strengths
AnGes Inc – Weaknesses
AnGes Inc – Opportunities
AnGes Inc – Threats
AnGes Inc – Key Competitors
Section 3 – Company Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Performance Chart
Financial Performance
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts
Section 4 – Company’s Lifesciences Financial Deals and Alliances
AnGes Inc, Pharmaceuticals & Healthcare, Deals By Year, 2015 to YTD 2021
AnGes Inc, Pharmaceuticals & Healthcare, Deals By Type, 2015 to YTD 2021
AnGes Inc, Recent Deals Summary
Section 5 – Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

List of Tables
AnGes Inc, Key Facts
AnGes Inc, Key Employees
AnGes Inc, Key Employee Biographies
AnGes Inc, Major Products and Services
AnGes Inc, History
AnGes Inc, Other Locations
AnGes Inc, Subsidiaries
AnGes Inc, Key Competitors
AnGes Inc, Ratios based on current share price
AnGes Inc, Annual Ratios
AnGes Inc, Annual Ratios (Cont...1)
AnGes Inc, Interim Ratios
AnGes Inc, Pharmaceuticals & Healthcare, Deals By Year, 2015 to YTD 2021
AnGes Inc, Pharmaceuticals & Healthcare, Deals By Type, 2015 to YTD 2021
AnGes Inc, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

★海外企業調査レポート[AnGes Inc (4563):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Republic Services Inc (RSG)-エネルギー分野:企業M&A・提携分析
    Summary Republic Services, Inc. (Republic) is a provider of non-hazardous solid waste and recycling services. The company collects, recycles, treats, and recovers and disposes waste. It owns or operates transfer stations, landfills, recycling centers, treatment, recovery and disposal facilities, and …
  • Salesforce.Com Inc (CRM):企業の財務・戦略的SWOT分析
    Salesforce.Com Inc (CRM) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Brokk AB:企業の戦略的SWOT分析
    Brokk AB - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. Thi …
  • A. O. Smith Corporation (AOS):企業の財務・戦略的SWOT分析
    A. O. Smith Corporation (AOS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakne …
  • Jardine Cycle & Carriage Limited:企業の戦略・SWOT・財務分析
    Jardine Cycle & Carriage Limited - Strategy, SWOT and Corporate Finance Report Summary Jardine Cycle & Carriage Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, produ …
  • Nielsen Holdings plc (NLSN):企業の財務・戦略的SWOT分析
    Nielsen Holdings plc (NLSN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakness …
  • NuVasive Inc (NUVA):製品パイプライン分析
    Summary NuVasive Inc (NuVasive) is a medical device company that provides minimally invasive, procedurally-integrated spine solutions. The company principally provides Maximum Access Surgery (MAS), a minimally-disruptive surgical platform. MAS platform enables surgeons to perform a range of minimall …
  • Sharp HealthCare:企業の戦略的SWOT分析
    Sharp HealthCare - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and servi …
  • Bayer AG (BAYN):製薬・医療:M&Aディール及び事業提携情報
    Summary Bayer AG (Bayer) carries out the research, development, production and commercialization of products for human and animal health care, and agriculture. It provides medicines for cardiovascular diseases, women’s health, cancer, hematology, ophthalmology and other indications. The company's pr …
  • AVX Corp (AVX):企業の財務・戦略的SWOT分析
    AVX Corp (AVX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the po …
  • Spotlight Innovation Inc (STLT):企業の財務・戦略的SWOT分析
    Summary Spotlight Innovation Inc (Spotlight Innovation), formerly American Exploration Corp is a developer of proprietary technologies designed to treat rare, emerging and neglected diseases. The company’s product pipeline includes drug candidates for the treatment of cancer derived from specialized …
  • Discovery Holdings Limited (DSY):企業の財務・戦略的SWOT分析
    Discovery Holdings Limited (DSY) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and wea …
  • Ardian Holding SAS:企業の戦略的SWOT分析
    Ardian Holding SAS - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and ser …
  • Hologic Inc (HOLX)-製薬・医療分野:企業M&A・提携分析
    Summary Hologic Inc (Hologic) is a medical device company. It develops, manufactures and supplies diagnostic products, medical imaging systems and surgical products. The company offers diagnostic products to aid in the diagnosis of human diseases and screen donated human blood; a broad portfolio of …
  • Tessa Therapeutics Pte Ltd-製薬・医療分野:企業M&A・提携分析
    Summary Tessa Therapeutics Pte Ltd (Tessa Therapeutics) is a clinical-stage biotechnology company that develops and commercializes cancer immunotherapies that redirect the body’s powerful anti-viral immune response to identify and exterminate cancer cells. The company provides products for various c …
  • NH Foods Ltd.:企業の戦略・SWOT・財務情報
    NH Foods Ltd. - Strategy, SWOT and Corporate Finance Report Summary NH Foods Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • Fronius International GmbH:企業の戦略的SWOT分析
    Fronius International GmbH - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products …
  • Mondi Limited:企業の戦略・SWOT・財務情報
    Mondi Limited - Strategy, SWOT and Corporate Finance Report Summary Mondi Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • Akcea Therapeutics Inc (AKCA):製薬・医療:M&Aディール及び事業提携情報
    Summary Akcea Therapeutics Inc (Akcea Therapeutics), a subsidiary of Ionis Pharmaceuticals Inc, is a developer and commercializer of drugs to treat patients with cardiometabolic diseases caused by lipid disorders. The company’s drugs are designed based on advanced antisense technology. Its pipeline …
  • Brady Corporation (BRC):企業の財務・戦略的SWOT分析
    Brady Corporation (BRC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses a …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆